[Tumor markers in focal and diffuse liver diseases].
The level of tumor markers (alpha-fetoprotein, carcinoembryonic antigen, ferritin, beta 2-microglobulin) in the blood serum was determined in 147 patients with benign and malignant hepatic diseases, 105 patients with cancer of extrahepatic site, Stage I-IV, without liver metastases (a control group) and 36 practically healthy persons. An analysis of the results obtained allowed one to establish that an increase in the concentration of tumor markers as compared to the normal one, is noted in both malignant and benign hepatic diseases as well as in the control group. However hepatic tumors were caused by a more frequent rise of the concentration of tumor markers in the blood serum with higher absolute values. Among benign hepatic diseases the most frequent increase in the level of tumor markers was noted in hepatitis and cirrhosis.
D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003937:Diagnosis, Differential; D005260:Female; D005293:Ferritins / Q000097:blood*; D006505:Hepatitis / Q000097:blood / Q000175:diagnosis; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000175:diagnosis; D008107:Liver Diseases / Q000097:blood* / Q000175:diagnosis; D008113:Liver Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000556:secondary; D008297:Male; D012727:Sex Characteristics; D000509:alpha-Fetoproteins / Q000032:analysis*; D001613:beta 2-Microglobulin / Q000032:analysis*
D002272:Carcinoembryonic Antigen; D000509:alpha-Fetoproteins; D001613:beta 2-Microglobulin; D005293:Ferritins
Opukholevye markery pri ochagovykh i diffuznykh zabolevaniiakh pecheni.